Patients’ willingness to take separate component antiretroviral therapy regimens for HIV in the Netherlands

Introduction The costs of combination antiretroviral therapy (cART) consisting of separate, particularly generic, components are generally much lower than of a single tablet regimen (STR) including the same active ingredients. Our aim was to evaluate whether patients in care in the Netherlands would be willing to take separate component regimens (SCR) instead of an STR and to examine whether willingness was associated with particular patient characteristics. Materials and Methods Data from the HIV Monitoring Foundation of all adult HIV‐1‐infected patients in care taking cART>6 months were u... Mehr ...